The Simplexa Flu A/B & RSV Direct kit from Focus Diagnostics, Cypress, Calif, has received FDA clearance for eight additional influenza strains, including H3N2v and the novel avian influenza A strain H7N9.
Read More
NIH funding leads to a new, low-cost molecular diagnostic instrument, with no electricity needed.
Read MoreSingapore-based Vela Diagnostics has announced completion of the FDA listing of its next-generation sequencing system as a Class II medical device.
Read More
In recent years, laboratories’ ability to detect and quantitate viruses through serology testing has significantly improved due to the use of molecular techniques.
Read More
Novel test from T2 Biosystems identifies five species of Candida, one of the most lethal forms of sepsis-causing bloodstream infections, providing results in hours instead of days.
Read More